Clinical Trials Browser

Observational × Neuroblastoma × dinutuximab × Clear all

NCT02693171 2019-08-05

Post-Marketing Assessment of Immunogenicity and Safety of Unituxin® in High-Risk Neuroblastoma Patients

13 enrolled 9 charts

Neuroblastoma